-
Je něco špatně v tomto záznamu ?
Seshat: A Web service for accurate annotation, validation, and analysis of TP53 variants generated by conventional and next-generation sequencing
T. Tikkanen, B. Leroy, JL. Fournier, RA. Risques, J. Malcikova, T. Soussi,
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články, práce podpořená grantem
Grantová podpora
R01 CA181308
NCI NIH HHS - United States
PubMed
29696732
DOI
10.1002/humu.23543
Knihovny.cz E-zdroje
- MeSH
- anotace sekvence MeSH
- databáze genetické * MeSH
- genetická variace genetika MeSH
- genomika trendy MeSH
- internet MeSH
- lidé MeSH
- mutace MeSH
- nádorový supresorový protein p53 genetika MeSH
- software * MeSH
- výpočetní biologie trendy MeSH
- vysoce účinné nukleotidové sekvenování MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
Accurate annotation of genomic variants in human diseases is essential to allow personalized medicine. Assessment of somatic and germline TP53 alterations has now reached the clinic and is required in several circumstances such as the identification of the most effective cancer therapy for patients with chronic lymphocytic leukemia (CLL). Here, we present Seshat, a Web service for annotating TP53 information derived from sequencing data. A flexible framework allows the use of standard file formats such as Mutation Annotation Format (MAF) or Variant Call Format (VCF), as well as common TXT files. Seshat performs accurate variant annotations using the Human Genome Variation Society (HGVS) nomenclature and the stable TP53 genomic reference provided by the Locus Reference Genomic (LRG). In addition, using the 2017 release of the UMD_TP53 database, Seshat provides multiple statistical information for each TP53 variant including database frequency, functional activity, or pathogenicity. The information is delivered in standardized output tables that minimize errors and facilitate comparison of mutational data across studies. Seshat is a beneficial tool to interpret the ever-growing TP53 sequencing data generated by multiple sequencing platforms and it is freely available via the TP53 Website, http://p53.fr or directly at http://vps338341.ovh.net/.
Department of Pathology University of Washington Seattle Washington
Genevia Technologies Tampere Finland
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc19028461
- 003
- CZ-PrNML
- 005
- 20190822124249.0
- 007
- ta
- 008
- 190813s2018 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1002/humu.23543 $2 doi
- 035 __
- $a (PubMed)29696732
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Tikkanen, Tuomas $u Genevia Technologies, Tampere, Finland.
- 245 10
- $a Seshat: A Web service for accurate annotation, validation, and analysis of TP53 variants generated by conventional and next-generation sequencing / $c T. Tikkanen, B. Leroy, JL. Fournier, RA. Risques, J. Malcikova, T. Soussi,
- 520 9_
- $a Accurate annotation of genomic variants in human diseases is essential to allow personalized medicine. Assessment of somatic and germline TP53 alterations has now reached the clinic and is required in several circumstances such as the identification of the most effective cancer therapy for patients with chronic lymphocytic leukemia (CLL). Here, we present Seshat, a Web service for annotating TP53 information derived from sequencing data. A flexible framework allows the use of standard file formats such as Mutation Annotation Format (MAF) or Variant Call Format (VCF), as well as common TXT files. Seshat performs accurate variant annotations using the Human Genome Variation Society (HGVS) nomenclature and the stable TP53 genomic reference provided by the Locus Reference Genomic (LRG). In addition, using the 2017 release of the UMD_TP53 database, Seshat provides multiple statistical information for each TP53 variant including database frequency, functional activity, or pathogenicity. The information is delivered in standardized output tables that minimize errors and facilitate comparison of mutational data across studies. Seshat is a beneficial tool to interpret the ever-growing TP53 sequencing data generated by multiple sequencing platforms and it is freely available via the TP53 Website, http://p53.fr or directly at http://vps338341.ovh.net/.
- 650 _2
- $a výpočetní biologie $x trendy $7 D019295
- 650 12
- $a databáze genetické $7 D030541
- 650 _2
- $a genetická variace $x genetika $7 D014644
- 650 _2
- $a genomika $x trendy $7 D023281
- 650 _2
- $a vysoce účinné nukleotidové sekvenování $7 D059014
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a internet $7 D020407
- 650 _2
- $a anotace sekvence $7 D058977
- 650 _2
- $a mutace $7 D009154
- 650 12
- $a software $7 D012984
- 650 _2
- $a nádorový supresorový protein p53 $x genetika $7 D016159
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Leroy, Bernard $u Sorbonne Université, UPMC Univ Paris, Paris, France.
- 700 1_
- $a Fournier, Jean Louis $u Sorbonne Université, UPMC Univ Paris, Paris, France.
- 700 1_
- $a Risques, Rosa Ana $u Department of Pathology, University of Washington, Seattle, Washington.
- 700 1_
- $a Malcikova, Jitka $u Department of Internal Medicine - Hematology and Oncology, University Hospital Brno and Medical Faculty, Masaryk University, Brno, Czech Republic. Central European Institute of Technology, Masaryk University, Brno, Czech Republic.
- 700 1_
- $a Soussi, Thierry $u Sorbonne Université, UPMC Univ Paris, Paris, France. Department of Oncology-Pathology, Cancer Center Karolinska (CCK), Karolinska Institutet, Stockholm, Sweden. INSERM, Centre de Recherche des Cordeliers, U1138, Paris, France.
- 773 0_
- $w MED00002078 $t Human mutation $x 1098-1004 $g Roč. 39, č. 7 (2018), s. 925-933
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/29696732 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20190813 $b ABA008
- 991 __
- $a 20190822124528 $b ABA008
- 999 __
- $a ok $b bmc $g 1433610 $s 1066921
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2018 $b 39 $c 7 $d 925-933 $e 20180517 $i 1098-1004 $m Human mutation $n Hum Mutat $x MED00002078
- GRA __
- $a R01 CA181308 $p NCI NIH HHS $2 United States
- LZP __
- $a Pubmed-20190813